Post-approval studies (Phase 4)Ended earlyNCT01452152
What this trial is testing
Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Who this might be right for
Cardiovascular DiseasesAcute Coronary Syndrome
University of Maryland, Baltimore 9